Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lobaplatin + ethiodized poppyseed oil
- Development stage
- Phase 3
- Lead developer
- Guangxi Medical University
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Intra-arterial
01
Overview
lobaplatin + ethiodized poppyseed oil is a chemoembolic combination therapy being evaluated by Guangxi Medical University for the adjuvant treatment of hepatocellular carcinoma (HCC). The regimen involves the intra-arterial administration of lobaplatin, a third-generation platinum derivative, emulsified with ethiodized poppyseed oil (also known as Lipiodol). The ethiodized oil serves a dual purpose: it acts as a radio-opaque contrast agent for imaging and as a drug delivery vehicle that selectively accumulates in the hypervascular environment of HCC tumors. Once deposited, the oil provides a temporary embolic effect, while the lobaplatin induces tumor cell death by forming DNA cross-links and inhibiting DNA synthesis. This specific combination is currently in Phase III clinical trials as a postoperative adjuvant therapy to reduce recurrence rates in patients who have undergone curative hepatectomy for HCC with high-risk factors.
- Brand names
- EthiodolLobap
- Other names
- ethiodized poppyseed oiliodized oilethiodized oilLipiodol Ultra-Fluidlobaplatin
02
Targets
DNA
Beyond the preview
Go deeper on lobaplatin + ethiodized poppyseed oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lobaplatin + ethiodized poppyseed oil.